Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Mitchell

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Psychosocial Oncology|August 20, 2016
Personality and psychological distress among older adult, long-term cancer survivorsGary T Deimling, Casey Albitz, Kara Monnin, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 17, 2015
Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotypeAmanda Krause, Claire Mitchell, Fahmida Essop, et al.
Behaviour Research and Therapy|January 9, 2021
Delving into the detail: Greater episodic detail in narratives of a critical life event predicts an increase in adolescent depressive symptoms across one yearKaren Salmon, Laina Isler, Paul Jose, et al.
Clinical Rehabilitation|November 4, 2025
Post-stroke facial palsy: Prevalence, recovery patterns within the first 7 days, risk factors, and effect of hyperacute treatmentsZewen Lu, Havva Sumeyye Eroglu, Halvor Naess, et al.
BMJ Open|January 13, 2021
Challenges implementing a carer support intervention within a national stroke organisation: findings from the process evaluation of the OSCARSS trialSarah Darley, Sarah Knowles, Kate Woodward-Nutt, et al.
The Cochrane Database of Systematic Reviews|July 1, 2021
Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injuryVerity Longley, Christine Hazelton, Calvin Heal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian CancerRobert D Morgan, Andrew R Clamp, Jurjees Hasan, et al.
Purinergic Signalling|April 12, 2008
Stimulation of an alpha1-adrenergic receptor downregulates ecto-5' nucleotidase activity on the apical membrane of RPE cellsDavid Reigada, Xiulan Zhang, Ana Crespo, et al.
ESMO Open|April 10, 2019
Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancerRobert D Morgan, Sofia Stamatopoulou, Nerissa Mescallado, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2019
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancerRobert D Morgan, Andrew R Clamp, Cong Zhou, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Psychosocial Oncology|August 20, 2016
Personality and psychological distress among older adult, long-term cancer survivorsGary T Deimling, Casey Albitz, Kara Monnin, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 17, 2015
Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotypeAmanda Krause, Claire Mitchell, Fahmida Essop, et al.
Behaviour Research and Therapy|January 9, 2021
Delving into the detail: Greater episodic detail in narratives of a critical life event predicts an increase in adolescent depressive symptoms across one yearKaren Salmon, Laina Isler, Paul Jose, et al.
Clinical Rehabilitation|November 4, 2025
Post-stroke facial palsy: Prevalence, recovery patterns within the first 7 days, risk factors, and effect of hyperacute treatmentsZewen Lu, Havva Sumeyye Eroglu, Halvor Naess, et al.
BMJ Open|January 13, 2021
Challenges implementing a carer support intervention within a national stroke organisation: findings from the process evaluation of the OSCARSS trialSarah Darley, Sarah Knowles, Kate Woodward-Nutt, et al.
The Cochrane Database of Systematic Reviews|July 1, 2021
Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injuryVerity Longley, Christine Hazelton, Calvin Heal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian CancerRobert D Morgan, Andrew R Clamp, Jurjees Hasan, et al.
Purinergic Signalling|April 12, 2008
Stimulation of an alpha1-adrenergic receptor downregulates ecto-5' nucleotidase activity on the apical membrane of RPE cellsDavid Reigada, Xiulan Zhang, Ana Crespo, et al.
ESMO Open|April 10, 2019
Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancerRobert D Morgan, Sofia Stamatopoulou, Nerissa Mescallado, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2019
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancerRobert D Morgan, Andrew R Clamp, Cong Zhou, et al.
Pageof 7